The NICHD conducts and supports a variety of clinical research related to hypoparathyroidism. Select a link below to learn more about these projects.
Featured NICHD Clinical Trials
- Treatment of Hypoparathyroidism with Synthetic Human Parathyroid Hormone 1-34
For more than two decades, researchers conducting this study have been providing and evaluating a synthetic parathyroid hormone, known as PTH 1-34, for use in severe cases of hypoparathyroidism. This study examines the long-term effects of PTH therapy on calcium metabolism, bone, and renal function.
- Comparing Pump with Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic Hypoparathyroidism
This study evaluates the safety and effectiveness of pump-delivered PTH compared with twice-daily injections. The researchers hypothesize that the pump method will provide smoother metabolic control of serum mineral levels and normalization of urine mineral excretion.
NICHD Clinical Trials
ClinicalTrials.gov Search Results
Information on current NIH-sponsored clinical trials on hypoparathyroidism is available by following the link below or by calling 800-411-1222.